top of page
Updates from the Team


SeneX Therapeutics announces an exclusive license agreement with the Icahn School of Medicine at Mount Sinai
SeneX Therapeutics, a clinical-stage biopharmaceutical company, developing disruptive gene therapies for inflammatory and age-related...
drputter
Jul 18, 20242 min read
Â
Â
Â


Investing in Tomorrow: SeneX's Groundbreaking Research
Gene therapy is a groundbreaking field that has the potential to revolutionize the treatment of various diseases. One company at the...
drputter
Jun 7, 20241 min read
Â
Â
Â


Revolutionizing Biotech: SeneX's Innovative Gene Therapy
Gene therapy is at the forefront of revolutionizing biotechnology, offering promising solutions for a wide range of medical conditions....
drputter
Jun 7, 20242 min read
Â
Â
Â


Unlocking Potential: SeneX Gene Therapy Breakthroughs
In the realm of gene therapy breakthroughs, one company is making significant strides towards unlocking the potential of treating various...
drputter
Jun 7, 20242 min read
Â
Â
Â
bottom of page
